dystrophia myotonica type II muscle disorder
Conditions
Interventions
None listed
Sponsors
Sint Maartenskliniek
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: dystrophia myotonica type II informed consent
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of autoimmune disease according to clinical criteria or classification criteria in both cohorts | — |
Secondary
| Measure | Time frame |
|---|---|
| frequency of autoantibody fromation in both cohorts | — |
Countries
Netherlands
Outcome results
None listed